Asia Insurance Post
  • Home
  • Articles
  • Blog
  • Data
  • Facts
  • Editorial
  • Interviews
Select Page

Maharashtra FDA cancels Johnson & Johnson baby powder manufacturing license

by AIP Online Bureau | Sep 17, 2022 | Health, Indian News, Policy, Regulation

The press note said that the samples of Johnson’s Baby Powder were declared “Not of Standard Quality”. FDA Maharashtra had taken the samples of Johnson’s Baby Powder at Pune and Nashik for quality check purposes Mumbai: Food & Drugs...
Next Entries »

Recent Posts

  • Drone strike in Egypt sparks security concerns about Suez oil exports
  • India’s auto sector posts robust July sales on sustained SUV demand
  • CBI files Rs 1,816 crore EPFO investment fraud case against Reliance Capital
  • Saudi Arabia unveils plans for multinational maritime defence coalition
  • AI to reshape insurance economics, drive scale and specialisation: McKinsey

Categories

  • Articles
  • Banking & Bancassurance
  • Blog
  • Breaking News!
  • Briefs
  • Climate, Environment, Renewable Energy
  • Data
  • Disaster & Management
  • Eco/Invest/Demography
  • Editorial
  • Events
  • Facts
  • Features
  • Health
  • Indian News
  • Intermediaries
  • International News
  • Interviews
  • Life
  • Main Menu
  • Non-Life
  • Pandemic
  • Pension & Social Security
  • Policy
  • Regulation
  • Reinsurance
  • Risk Management
  • Simple
  • Technology
  • Trends, Facts
  • Uncategorized
  • Wealth Management/ Philanthropy
  • Workplace/Employee Benefits
  • Home
  • Articles
  • Blog
  • Data
  • Facts
  • Editorial
  • Interviews
  • Eco/Invest/Demography
  • Indian News
  • International News
  • Health
  • Non-Life
  • Pandemic
  • Technology
  • Risk Management
  • Reinsurance
  • Banking & Bancassurance
  • Wealth Management/ Philanthropy